La Jolla Pharmaceutical Company
NASDAQ: LJPC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- George Tidmarsh
- Employees
- 61
- Headquarters
- San Diego, United States
- IPO year
- 1994
- Website
- https://www.lajollapharmaceutical.com
Loading LJPC…
Loading profile data…Frequently asked questions about LJPC
What does La Jolla Pharmaceutical Company (LJPC) do?
La Jolla Pharmaceutical Company is dedicated to the creation and marketing of therapeutic solutions, with the ultimate goal of enhancing patient outcomes in the face of life-threatening illnesses. The company's commercialized offerings include GIAPREZA, a potent vasoconstrictor designed to raise blood pressure in adult patients afflicted by sept...
Where does LJPC trade?
La Jolla Pharmaceutical Company (LJPC) trades on the NASDAQ Capital Market.
What sector is LJPC in?
La Jolla Pharmaceutical Company (LJPC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of La Jolla Pharmaceutical Company?
George Tidmarsh is the chief executive officer of La Jolla Pharmaceutical Company (LJPC).
Where is La Jolla Pharmaceutical Company headquartered?
La Jolla Pharmaceutical Company is headquartered in United States.
Does LJPC pay a dividend?
La Jolla Pharmaceutical Company (LJPC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LJPC go public?
La Jolla Pharmaceutical Company (LJPC) completed its initial public offering in 1994.